Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploring CYP2D6 polymorphisms and angiotensin receptor blocker response in the Bai hypertensive population.

Pharmacogenetics and genomics - 1 Aug 2024

Yang Canbiao, Zhang Guoqiang, Shu Chang, Lv Linxi, Liu Zhengxing, Tian Yan, Tan Qi, Wang Zhaobin, Hu Songnian, Yang Libo, Sun Ningling

Abstract excerpt

OBJECTIVE: The CYP2D6 enzyme is crucial for the metabolism and disposition of a variety of drugs. This study was conducted to examine the relationship between CYP2D6 gene polymorphisms and the response to angiotensin receptor blocker (ARB)-based treatment in patients of Chinese Bai ethnicity with hypertension. METHODS: Seventy-two hypertensive adults from the Chinese Bai ethnic group, exhibiting systolic blood...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin Receptor Antagonists
Share to Antihypertensive Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Pressure

Share to Cytochrome P-450 CYP2D6

Share to East Asian People

Share to Ethnicity

Share to Hypertension

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 38848263
DOI: 10.1097/FPC.0000000000000537
PMCID: PMC11221794

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploring CYP2D6 polymorphisms and angiotensin receptor blocker response in the Bai hypertensive population.PMID 38848263Read ↗

Han Chinese specific cytochrome P450 polymorphisms and their impact on the metabolism of anti-hypertensive drugs with adrenoreceptor blocking properties.Semantic proximity Read ↗

Genetic and phenotypic frequency distribution of ACE, ADRB1, AGTR1, CYP2C9*3, CYP2D6*10, CYP3A5*3, NPPA and factors associated with hypertension in Chinese Han hypertensive patients.Semantic proximity Read ↗

Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.Semantic proximity Read ↗

Association between angiotensinogen, angiotensin II receptor genes, and blood pressure response to an angiotensin-converting enzyme inhibitor.Semantic proximity Read ↗

Genome‐wide Association Studies Categorized by Class of Antihypertensive Drugs Reveal Complex Pathogenesis of Hypertension with Drug ResistanceSemantic proximity Read ↗

Genetic polymorphisms of VKORC1, CYP2C9, CYP4F2 in Bai, Tibetan Chinese.Semantic proximity Read ↗

Associations between antihypertensive drug-related gene polymorphisms and cardiovascular outcomes in hypertensive patients: a gene-drug interaction study.Semantic proximity Read ↗

The Association of ADRB1 and CYP2D6 Polymorphisms With Antihypertensive Effects and Analysis of Their Contribution to Hypertension Risk.Semantic proximity Read ↗

Genetic association study of ABCB1 gene polymorphisms with hypertension in Han Chinese population.Semantic proximity Read ↗

Genetic polymorphism of CYP2D6 gene among Egyptian hypertensive casesSemantic proximity Read ↗

Associations between ADRB1 and CYP2D6 gene polymorphisms and the response to β-blocker therapy in hypertension.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.